Literature DB >> 2036896

[Surgical treatment results in colonic obstruction].

R Roscher1, R Frank, R Wagner, F Safi, H G Beger.   

Abstract

Between 1982 and 1988 94 patients with obstruction of the colon were operated (52 male, 42 female, median age 66 years). Carcinoma accounted for the majority of cases: in 51% of patients enteral, in 9% local tumor growth extraenteral, in 17% peritoneal carcinosis. Therapeutic procedures were chosen according to the necessities in benign courses and in extraenteral tumor growth. In obstructing colorectal carcinoma (48 patients) a policy of primary tumor resection was pursued. 48 patients (40%) developed postoperative complications, 3 patients (3.1%) had to be reoperated. The overall mortality rate in patients with acute obstructions of all courses was 9.6%, in patients with obstruction secondary to carcinoma 14.6%. 74% of patients with colorectal tumors had TNM tumor stage III and IV. The 5-years-survival rate amounted to 21% overall, but after primary tumor resection it was 47%.

Entities:  

Mesh:

Year:  1991        PMID: 2036896

Source DB:  PubMed          Journal:  Chirurg        ISSN: 0009-4722            Impact factor:   0.955


  3 in total

1.  [Results of mechanical ileus].

Authors:  R Roscher
Journal:  Chirurg       Date:  2007-07       Impact factor: 0.920

2.  Tumour Lymphocytic Infiltration, Its Structure and Influence in Colorectal Cancer Progression.

Authors:  Gjorgji Trajkovski; Ljubomir Ognjenovic; Gjorgji Jota; Dragan Hadzi-Manchev; Vanja Trajkovska; Goce Volcevski; Dafina Nikolova; Gordana Petrushevska; Vesna Janevska; Vlado Janevski
Journal:  Open Access Maced J Med Sci       Date:  2018-06-18

3.  Tertiary Lymphoid Structures in Colorectal Cancers and Their Prognostic Value.

Authors:  Gjorgji Trajkovski; Ljubomir Ognjenovic; Zoran Karadzov; Gjorgji Jota; Dragan Hadzi-Manchev; Ognen Kostovski; Goce Volcevski; Vanja Trajkovska; Dafina Nikolova; Liljana Spasevska; Vesna Janevska; Vlado Janevski
Journal:  Open Access Maced J Med Sci       Date:  2018-10-09
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.